Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Schulze

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmazie in Unserer Zeit|February 14, 2014
[Not Available]Axel Dignaß, Franz Hartmann, Hermann Schulze, et al.
Crohn'S & Colitis 360|February 13, 2023
Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases-LISTEN 1Niels Teich, Hermann Schulze, Jana Knop, et al.
Scandinavian Journal of Gastroenterology|March 22, 2018
A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patientsHermann Schulze, Philip Esters, Franz Hartmann, et al.
United European Gastroenterology Journal|June 26, 2020
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's diseaseWolfgang Alexander Seeger, Juliane Thieringer, Philip Esters, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmazie in Unserer Zeit|February 14, 2014
[Not Available]Axel Dignaß, Franz Hartmann, Hermann Schulze, et al.
Crohn'S & Colitis 360|February 13, 2023
Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases-LISTEN 1Niels Teich, Hermann Schulze, Jana Knop, et al.
Scandinavian Journal of Gastroenterology|March 22, 2018
A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patientsHermann Schulze, Philip Esters, Franz Hartmann, et al.
United European Gastroenterology Journal|June 26, 2020
Moderate endurance and muscle training is beneficial and safe in patients with quiescent or mildly active Crohn's diseaseWolfgang Alexander Seeger, Juliane Thieringer, Philip Esters, et al.
Pageof 1